Editorial Board

Editor-in-Chief
Professor Dr. Philip H. Elsinga, PhD, University of Groningen, Groningen, Netherlands

Associate Editors
Dr. Martin Behe, PhD, Paul Scherrer Institute, Villigen, Germany
Dr. Oliver C. Kiss, PhD, Helmholtz-Zentrum Dresden-Rossendorf (HZDR) Dresden, Germany
Professor Peter J. H. Scott, PhD, University of Michigan, Ann Arbor, MI, United States of America
Sarah Spreckelmeyer, PhD, Charité – University Hospital Berlin, Germany
Director of Research Jun Toyohara, PhD, Tokyo Metropolitan Institute for Geriatrics and Gerontology, Tokyo, Japan

Editorial Board
Em. Professor Silvio Aime, University of Torino, Italy
Postdoctoral Scholar Javier Ajenjo, PhD, Stanford University, CA, United States of America
Marta de Souza Albernaz, PhD, Hospital Universitário Clementino Fraga Filho, Universidade Federal do Rio de Janeiro, Brazil
Senior Scientist Mohammed Al-Qahtani, PhD, FRSC, Cyclotron and Radiopharmaceuticals Department, Research & Innovation, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia
Francisco Alves, PhD, ICNAS-Institute for Nuclear Sciences Applied to Health, University of Coimbra, Portugal
Professor Miguel Avila-Rodriguez, PhD, National Autonomous University of Mexico (UNAM), Mexico City, Mexico
Dr. Naoual Bentaleb, PharmD, National Center for Nuclear Energy, Science and Technology (CNESTEN), Rabat, Morocco
Emerson S. Bernardes, PhD, Nuclear and Energy Research Institute - IPEN, São Paulo, Brazil
Dr. Cécile Bourdeau, Radiopharmacist, Deputy Director, GIP Arronax, Saint-Herblain, France
Associate Professor Mickael Bourgeois, PhD, PharmD, Radiopharmacist, Nantes University Hospital - Nuclear Medicine Department, France ARRONAX Cyclotron - Radiopharmacy Unit, France Nantes University, Faculty of Pharmacy - Galenic/Biophysic Department, France
Professor Peter Caravan, PhD, Massachusetts General Hospital, Harvard Medical School, Boston, MA, United States of America
Assistant Professor Dr. Giuseppte Carlucci, University of California, Los Angeles, CA, United States of America
Emiliano Cazzola, PhD, IRCCS Sacro Cuore, Negrar, Italy
Assistant Professor Ivis F. Chaple Gore, PhD, University of Tennessee Knoxville, TN, United States of America
Professor Zhen Cheng, PhD, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China
Assistant Professor Frederik Cleeren, PhD, Katholieke Universiteit, Leuven, Belgium
Associate Professor Dr. Bart Cornelissen, PhD, Oxford University, United Kingdom, and University Medical Center Groningen, Netherlands
Professor Jean N. DaSilva, PhD, University of Montreal, QC, Canada
Professor Mag.pharm. Dr.  Clemens Decristoforo, Medical University Innsbruck, Austria
Associate Professor Antonia Denkova, PhD, Delft University of Technology, Netherlands
Dr. Winnie Deuther-Conrad, PhD, Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Leipzig, Germany
Professor Adriano Duatti, University of Ferrara, Italy
Dr. Fany Pricile Ekoume, PhD, General Hospital & University of Yaoundé 1, Yaoundé, Cameroon
Beverley L. Ellis, PhD, MRSC, MRPharmS, Cchem, Manchester University NHS Foundation Trust, Manchester, United Kingdom
Dr. Amal Elrefaei, Lecturer of Radiopharmacy, International Atomic Energy Agency (IAEA) and Section of Radiolabeld Compounds, Radioisotopes Production Division, Hot Laboratory Centre, Atomic Energy Authority of Egypt, Austria
Associate Professor Jonathan W. Engle, PhD, University of Wisconsin, Madison, WI, United States of America
Ines Farinha Antunes, PhD, University Medical Center Groningen, Groningen, Netherlands
Professor Shozo Furumoto, PhD, Tohoku University, Sendai, Japan
Professor Antony David Gee, PhD, PGCE, FSRS, King’s College, London, United Kingdom
Nic Gillings, PhD, Copenhagen University Hospital Rigshospitalet, Denmark
Dr. Jeroen J. M. A. Hendrikx, PhD, PharmD, Netherlands Cancer Institute Amsterdam (NKI), Netherlands
Senior Researcher Cornelia Hoehr, PhD, TRIUMF, Vancouver, BC, Canada
Dr. Ya-Yao Huang, PhD, Primo Biotechnology, Taipei, Taiwan
Dr. Amir R. Jalilian, PhD, Mag. Pharm., PharmD, International Atomic Energy Agency, Vienna, Austria
Professor Hongmei Jia, PhD, Beijing Normal University, Beijing, China
Maryke Kahts, BPharm, MSc (Med), Sefako Makgatho Health Sciences University, Ga-Rankuwa, South Africa
Full Professor (W3) Klaus Kopka, PhD, Institute of Radiopharmaceutical Cancer Research, Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Faculty of Chemistry and Food Chemistry, School of Science, Technical University Dresden (TUD), Germany
Assistant Professor Yohannes Jorge Lagebo, MSc, University of Addis Ababa, Ethiopia
Professor Suzanne Lapi, PhD, FSNMMI, University of Alabama at Birmingham, AL, United States of America
Peter Laverman, PhD, Radboud Medical Center, Nijmegen, Netherlands
Assistant Professor Xiang-Guo Li, PhD, University of Turku, Turku, Finland
Associate Professor Zijing Li, PhD, Xiamen University, Xiamen, China
Professor Zhaofei (Jeff) Liu, PhD, Peking University, China
Dr. Filippo Lodi, PhD, Radiopharmacist, IRCCS, University of Bologna, Italy
Professor Bob Mach, PhD, University of Pennsylvania, Philadelphia, PA, United States of America
Professor Yubin Miao, PhD, University of Colorado Denver, Aurora, CO, United States of America
Assistant Professor Oskar Middel, PhD, NTNU Trondheim, Norway
Professor Renata Mikolajczak, PhD, DSc, National Centre for Nuclear Research, Radioisotope Centre POLATOM, Otwock, Poland
Archana Mukherjee, Bhabha Atomic Research Centre & Homi Bhabha National Institute, Mumbai, India
Jan Passchier, PhD, MSc, FRSC, FRSB, Invicro London, United Kingdom
Professor Dr. Marianne Patt, Radiochemist, Radiopharmacist, University Hospital of Augsburg, Germany
Professor Ivan Penuelas, PhD, Radiopharmacist, University Clinic of Navarra, Pamplona, Spain
Lars R. Perk, PhD, Radboud University Medical Center Nijmegen, Netherlands
Dr. Maroor Raghavan Ambikalmajan Pillai, PhD, D.Sc, Molecular Group of Companies, Cochin, India
Assistant Professor Caterina Ramogida, PhD, Simon Fraser University & TRIUMF, Burnaby, BC, Canada
Professor Raymond M. Reilly, PhD, BScPhm , MScPhm, University of Toronto, ON, Canada
Professor Ana Maria Rey Rios, Professor of Radiochemistry, PhD in Chemistry, Area Radioquímica, Facultad de Química, Universidad de la República, Montevideo
Emeritus Associate Professor Sietske Rubow, PhD, Stellenbosch University, Stellenbosch, South Africa
Professor Tamer M. Sakr, PhD, NDC, Egyptian Atomic Energy Authority, Cairo, Egypt
Assistant Professor Maria J.  Salgueiro, PhD, BioCh, Pharm, Physics Department, School of Pharmacy and Biochemistry, University of Buenos Aires, Argentina
Professor Ralph Santos-Oliveira, PhD, Brazilian Nuclear Energy Commission, Nuclear Engineering Institute and Sate University of Rio de Janeiro, Faculty of Pharmacy, Rio de Janeiro, Brazil
Eduardo Savio, PhD, Uruguayan Center for Molecular Imaging (CUDIM), Uruguay
Professor Dr. Ralph Schirrmacher, PhD, University of Alberta, Cross Cancer Institute, Medical Isotope and Cyclotron Facility, Affiliated member Chemistry and Pharmacy, University of Alberta, Edmonton, AB, and Adjunct member TRIUMF, Vancouver, BC, Canada
Assistant Professor Yann Seimbille, Erasmus MC, Rotterdam, Netherlands
Professor Beverley Summers, PhD, B Pharm, MSc Med (Pharmacy) cum laude, Sefako Makgatho Health Sciences University, Pretoria, South Africa
Professor Wiktor Szymanski, PhD, University of Groningen, Netherlands
Dr. Carlotta Taddei, PhD, Life Molecular Imaging GmbH, Berlin, Germany
Dr. Sergio Todde, PhD, Senior Researcher, University of Milano-Bicocca, Monza, Italy
Professor R. Michael van Dam, PhD, University of California Los Angeles, CA, United States of America
Nicholas van der Meulen, PhD, Paul Scherrer Institute, Villigen, Switzerland
Professor Vladimir Tolmachev, PhD, Uppsala University, Uppsala, Sweden
Johnny Vercouillie, PhD, University of Tours, France
Professor Danielle J. Vugts, PhD, Amsterdam UMC, Location Vumc, Amsterdam, Netherlands
Hua Yang, PhD, Research Scientist, TRIUMF, Vancouver, BC, Canada
Professor Min Yang, PhD, Jiangsu Institute of Nuclear Medicine, China
Professor Xing Yang, PhD, Peking University First Hospital, Beijing, China
Professor Zhi Yang, PhD, Director of Peking University Cancer Hospital& Institute, Beijing, China
Dr. Daniel L. Yokell, Pharm.D, RPh, BCNP, Telix Pharmaceuticals, Boston, MA, United States of America
Professor Jan Rijn Zeevaart, PhD, Necsa, NuMeRI NPC, University of Pretoria, South Africa
Director Ming-Rong Zhang, PhD, National Institutes for Quantum Science and Technology, Chiba, Japan
Professor Junbo Zhang, PhD, Beijing Normal University, Beijing, China
Hua Zhu, Peking University Cancer Hospital, Beijing, China
Professor Marcela Zubillaga, PhD, University of Buenos Aires, Argentina